Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non-Current Assets (2017 - 2024)

KalVista Pharmaceuticals' Other Non-Current Assets history spans 9 years, with the latest figure at $1.4 million for Q4 2024.

  • For Q4 2024, Other Non-Current Assets changed N/A year-over-year to $1.4 million; the TTM value through Dec 2024 reached $1.4 million, changed N/A, while the annual FY2024 figure was $567000.0, N/A changed from the prior year.
  • Other Non-Current Assets for Q4 2024 was $1.4 million at KalVista Pharmaceuticals, up from $662000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.4 million in Q4 2024 and bottomed at $106000.0 in Q3 2023.
  • The 4-year median for Other Non-Current Assets is $259000.0 (2021), against an average of $411750.0.
  • The largest annual shift saw Other Non-Current Assets changed 0.0% in 2020 before it soared 470.75% in 2024.
  • A 4-year view of Other Non-Current Assets shows it stood at $178000.0 in 2020, then grew by 1.69% to $181000.0 in 2021, then skyrocketed by 86.19% to $337000.0 in 2023, then skyrocketed by 309.2% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Other Non-Current Assets are $1.4 million (Q4 2024), $662000.0 (Q4 2024), and $605000.0 (Q3 2024).